⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31541860 | 0.82 | — | — | |
| SCHEMBL9153027 | 0.75 | — | — | |
| SCHEMBL11515185 | 0.73 | — | — | |
| SCHEMBL317444 | 0.72 | — | — | |
| SCHEMBL6735949 | 0.72 | — | — | |
| SCHEMBL5685676 | 0.69 | — | — | |
| SCHEMBL10513597 | 0.69 | — | — | |
| SCHEMBL3798436 | 0.69 | — | — | |
| SCHEMBL4866725 | 0.69 | — | — | |
| SCHEMBL16594801 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119301456-A | Detection of liver disease | 奥斯通医疗有限公司 | 2025-01-10 | — | — | CN | disclosed |
| WO-2023223040-A1 | DETECTION OF LIVER DISEASE | OWLSTONE MEDICAL LIMITED (GB) | 2023-11-23 | — | — | WO | disclosed |
| US-20210341461-A1 | DIAGNOSIS OF CANCER | OWLSTONE MEDICAL LIMITED (GB) | 2021-11-04 | — | — | US | disclosed |
| EP-3847272-A1 | DIAGNOSIS OF CANCER | Owlstone Medical Limited (GB) | 2021-07-14 | — | — | EP | disclosed |
| CN-112673111-A | Diagnosis of cancer | 奥斯通医疗有限公司 | 2021-04-16 | — | — | CN | disclosed |